[E. 39 and sarcomatosis].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D012509:Sarcoma
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; LYMPHOSARCOMA/therapy; SARCOMA, RETICULUM CELL/therapy
E. 39 et sarcomatoses.